Gainers
- Cara Therapeutics CARA stock rose 22.54% to $17.5 during Monday's after-market session. Trading volume for this security closed at 2.3 million, accounting for 399.77% of its average full-day volume over the last 100 days. The company's market cap stands at $876.5 million.
- TransCode Therapeutics RNAZ stock moved upwards by 15.8% to $3.26. At the close, TransCode Therapeutics's trading volume reached 1.4 million shares. This is 87.28% of its average volume over the last 100 days. The market value of their outstanding shares is at $39.0 million.
- Evolus EOLS stock rose 4.54% to $11.5. The market value of their outstanding shares is at $627.6 million.
- Otonomy OTIC stock moved upwards by 4.34% to $1.44. The company's market cap stands at $81.6 million.
- Aclaris Therapeutics ACRS shares increased by 3.88% to $14.99. The company's market cap stands at $917.6 million.
- Novo Integrated Sciences NVOS shares moved upwards by 3.35% to $1.85. The market value of their outstanding shares is at $49.0 million.
Losers
- Regencell Bioscience RGC shares decreased by 6.85% to $12.8 during Monday's after-market session. The market value of their outstanding shares is at $161.8 million.
- NeuroOne Medical Tech NMTC stock fell 6.11% to $4.15. The company's market cap stands at $49.8 million.
- Macrogenics MGNX stock fell 5.95% to $22.0. Today's trading volume for this security ended up closing at 98.2K shares, which is 14.06 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion.
- Biolase BIOL shares declined by 3.22% to $0.69. The market value of their outstanding shares is at $104.1 million.
- Protagenic Therapeutics PTIX stock fell 2.92% to $2.0. The market value of their outstanding shares is at $33.3 million. As per the news, the Q2 earnings report came out 4 days ago.
- Intercept Pharmaceuticals ICPT shares declined by 2.35% to $13.75. The market value of their outstanding shares is at $456.5 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in